#USA #New York #Securities Fraud #Pomerantz LLP #Sensus Healthcare

Pomerantz Law Firm Investigates Possible Securities Fraud by Sensus Healthcare

Pomerantz LLP has initiated an investigation into potential securities fraud involving Sensus Healthcare, Inc. (NASDAQ: SRTS). The firm is asking investors who may have suffered financial losses to reach out for further information and to discuss potential legal actions. This inquiry is critical as it focuses on whether Sensus's management engaged in illicit business practices that could have misled investors.

The investigation follows concerning findings released by Sensus on August 7, 2025, regarding their financial results for the second quarter of the year. The company reported a GAAP earnings-per-share of -$0.06, missing expectations by $0.09. Additionally, they reported revenues of $7.3 million, a staggering 20.7% decline from the previous year’s figures, which also came in short of estimates by $2 million. Sensus attributed this downturn primarily to a drop in unit sales to a significant customer, even though some growth was noted in recurring revenue through Fair Deal Agreements.

Unsurprisingly, the revelation caused a sharp drop in Sensus's stock value. On August 8, 2025, shares plummeted by $1.89, reflecting a 35.32% decline, closing the day at just $3.46 per share. Such a drastic change raises legitimate concerns among investors about the company's current and future standing.

Pomerantz LLP, a distinguished law firm with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is recognized for its work in corporate, securities, and antitrust class litigation. The firm's legacy can be traced back over 85 years to its founder, Abraham L. Pomerantz, who is known as a pioneering figure in the field of securities fraud litigation. His commitment to delivering justice for victims of corporate misconduct continues to be a driving force for the firm today.

The firm has successfully recovered numerous multi-million dollar awards for class members impacted by corporate malfeasance over the years. With robust experience in dealing with complex securities cases, Pomerantz LLP aims to protect the rights of investors who might have been harmed by the actions of Sensus Healthcare.

If you believe you have been affected by the recent downturn at Sensus Healthcare or have insights related to the company's operational shortfalls, you are encouraged to contact Danielle Peyton at Pomerantz LLP. She can be reached via email at [email protected] or by phone at 646-581-9980, ext. 7980. It’s imperative for investors to stay informed and consider their options, especially in light of a potentially significant class action suit that could arise from these investigations.

The Pomerantz firm is committed to ensuring all investors stand a chance in recouping their losses during this turbulent time, upholding their historical promise of fighting against securities fraud and corporate misconduct. This ongoing investigation represents an opportunity for affected investors to seek recourse and obtain the support they need from a reputable legal partner.